FDA.reportPublic FDA data

bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray

RxCUI
1089113
RxNorm name
bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray
Display name
Bacitracin/Dimethicone/Zinc oxide (Topical)
Full name
bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray
Term type
SCD
Status
Active
Strength
0.5-200-250 var units
Dose form
Spray
Route
Topical
Updated
2026-06-14 07:06:40

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032011
Active start
032011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
zinc oxide250 MG / 1 MLzinc oxidezinc oxide
bacitracin zinc0.5 UNT / 1 MLbacitracinbacitracin
dimethicone200 MG / 1 MLdimethiconedimethicone

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Spray346165

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
zinc oxide11423
bacitracin1291
dimethicone324072

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRbacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical SprayNAMES
RxNorm Namebacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical SprayNAMES
RxNorm Synonymbacitracin 0.5 UNT/ML / dimethicone 20 % / zinc oxide 25 % Topical SprayNAMES
RxNorm SynonymBacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / ZNO 250 MG/ML Topical SprayNAMES
TTYSCDATTRIBUTES
RxCUI1089113CODES
MMSL_CODECD26881CODES

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f439fb97-0722-42ee-bc90-67daf0497aa8bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical SpraySCD2RASH RELIEF ANTIBACTERIAL SPRAY20111116
f439fb97-0722-42ee-bc90-67daf0497aa8bacitracin 500 UNT/GM / dimethicone 20 % / zinc oxide 25 % Topical SprayPSN2RASH RELIEF ANTIBACTERIAL SPRAY20111116
f439fb97-0722-42ee-bc90-67daf0497aa8Bacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / ZNO 250 MG/ML Topical SpraySY2RASH RELIEF ANTIBACTERIAL SPRAY20111116
f439fb97-0722-42ee-bc90-67daf0497aa8bacitracin 0.5 UNT/ML / dimethicone 20 % / zinc oxide 25 % Topical SpraySY2RASH RELIEF ANTIBACTERIAL SPRAY20111116

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01AAAntibioticsATC1-4bacitracin
ATCR02ABAntibioticsATC1-4bacitracin
ATCJ01XXOther antibacterialsATC1-4bacitracin
ATCD06AXOther antibiotics for topical useATC1-4bacitracin
ATCP03AXOther ectoparasiticides, incl. scabicidesATC1-4dimethicone
FDASPLN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
FDASPLN0000010282Skin Barrier ActivityPEhas_pedimethicone
MEDRTD001414BacitracinCHEMhas_ingredientbacitracin
MEDRTD004129DimethylpolysiloxanesCHEMhas_ingredientdimethicone
MEDRTD015034Zinc OxideCHEMhas_ingredientzinc oxide
MEDRTD019080Cafe-au-Lait SpotsDISEASEmay_preventzinc oxide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatzinc oxide
MEDRTD003963Diaper RashDISEASEmay_treatzinc oxide
MEDRTD004342Drug HypersensitivityDISEASEci_withzinc oxide
MEDRTD004342Drug HypersensitivityDISEASEci_withbacitracin
MEDRTD004485EczemaDISEASEmay_treatzinc oxide
MEDRTD004653EmpyemaDISEASEmay_treatbacitracin
MEDRTD004761Enterocolitis, PseudomembranousDISEASEmay_treatbacitracin
MEDRTD015818Eye Infections, BacterialDISEASEmay_treatbacitracin
MEDRTD007674Kidney DiseasesDISEASEci_withbacitracin
MEDRTD011014PneumoniaDISEASEmay_treatbacitracin
MEDRTD012868Skin AbnormalitiesDISEASEmay_preventdimethicone
MEDRTD012868Skin AbnormalitiesDISEASEmay_treatdimethicone
MEDRTD017192Skin Diseases, BacterialDISEASEmay_preventbacitracin
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatbacitracin
MEDRTD012878Skin NeoplasmsDISEASEmay_preventzinc oxide
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatbacitracin
MEDRTD013471SunburnDISEASEmay_preventzinc oxide
MEDRTD014947Wounds and InjuriesDISEASEmay_treatzinc oxide
MEDRTN0000009954Cell Membrane Fusion Complex InteractionsMOAhas_moabacitracin
MEDRTN0000000163Enzyme InteractionsMOAhas_moabacitracin
MEDRTN0000000065Physiochemical ActivityMOAhas_moazinc oxide
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pebacitracin
MEDRTN0000010282Skin Barrier ActivityPEhas_pedimethicone
MEDRTN0000009881Sunscreening ActivityPEhas_pezinc oxide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.5 UNT/ML / 200 MG/ML / 250 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESMMSL_CODECD26881
CODESRxCUI1089113
NAMESPrescribable Synonymbacitracin 500 UNT/GM / dimethicone 20 % / zinc oxide 25 % Topical Spray
NAMESRXNAV_STRbacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray
NAMESRxNorm Namebacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / zinc oxide 250 MG/ML Topical Spray
NAMESRxNorm Synonymbacitracin 0.5 UNT/ML / dimethicone 20 % / zinc oxide 25 % Topical Spray
NAMESRxNorm SynonymBacitracin 0.5 UNT/ML / dimethicone 200 MG/ML / ZNO 250 MG/ML Topical Spray
SOURCESSourceNational Drug Data File Plus Source Vocabulary